nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—PTGS2—atherosclerosis	0.188	1	CbGaD
Bumetanide—SLC22A11—Pravastatin—atherosclerosis	0.104	0.176	CbGbCtD
Bumetanide—SLC22A7—Pravastatin—atherosclerosis	0.099	0.167	CbGbCtD
Bumetanide—SLCO1A2—Rosuvastatin—atherosclerosis	0.0763	0.129	CbGbCtD
Bumetanide—SLCO1A2—Simvastatin—atherosclerosis	0.0709	0.12	CbGbCtD
Bumetanide—SLCO1A2—Pravastatin—atherosclerosis	0.0694	0.117	CbGbCtD
Bumetanide—SLCO1A2—Lovastatin—atherosclerosis	0.0694	0.117	CbGbCtD
Bumetanide—SLC22A8—Pravastatin—atherosclerosis	0.0604	0.102	CbGbCtD
Bumetanide—SLC22A6—Pravastatin—atherosclerosis	0.0421	0.0712	CbGbCtD
Bumetanide—SLC12A1—appendage—atherosclerosis	0.00336	0.143	CbGeAlD
Bumetanide—Upset stomach—Lovastatin—atherosclerosis	0.00265	0.0252	CcSEcCtD
Bumetanide—Upset stomach—Simvastatin—atherosclerosis	0.00247	0.0235	CcSEcCtD
Bumetanide—Blood disorder—Rosuvastatin—atherosclerosis	0.00245	0.0233	CcSEcCtD
Bumetanide—Hyperventilation—Niacin—atherosclerosis	0.00216	0.0206	CcSEcCtD
Bumetanide—Cholestasis—Niacin—atherosclerosis	0.00196	0.0186	CcSEcCtD
Bumetanide—Gynaecomastia—Rosuvastatin—atherosclerosis	0.00183	0.0174	CcSEcCtD
Bumetanide—Musculoskeletal pain—Lovastatin—atherosclerosis	0.00175	0.0167	CcSEcCtD
Bumetanide—Hepatocellular injury—Ezetimibe—atherosclerosis	0.0017	0.0162	CcSEcCtD
Bumetanide—Hepatocellular injury—Simvastatin—atherosclerosis	0.00162	0.0154	CcSEcCtD
Bumetanide—Hyperuricaemia—Niacin—atherosclerosis	0.0016	0.0153	CcSEcCtD
Bumetanide—Gynaecomastia—Lovastatin—atherosclerosis	0.00155	0.0148	CcSEcCtD
Bumetanide—Hearing impaired—Pravastatin—atherosclerosis	0.00154	0.0146	CcSEcCtD
Bumetanide—Blood uric acid increased—Niacin—atherosclerosis	0.00152	0.0144	CcSEcCtD
Bumetanide—Musculoskeletal pain—Pravastatin—atherosclerosis	0.00148	0.0141	CcSEcCtD
Bumetanide—Hepatocellular injury—Pravastatin—atherosclerosis	0.00147	0.0139	CcSEcCtD
Bumetanide—Gynaecomastia—Simvastatin—atherosclerosis	0.00145	0.0138	CcSEcCtD
Bumetanide—PTGS2—leg—atherosclerosis	0.00144	0.0614	CbGeAlD
Bumetanide—SLC12A4—cardiovascular system—atherosclerosis	0.00144	0.0613	CbGeAlD
Bumetanide—Gynaecomastia—Pravastatin—atherosclerosis	0.00131	0.0125	CcSEcCtD
Bumetanide—PTGS2—hindlimb—atherosclerosis	0.00129	0.0548	CbGeAlD
Bumetanide—SLC12A4—adipose tissue—atherosclerosis	0.00127	0.0541	CbGeAlD
Bumetanide—Pancreatitis—Rosuvastatin—atherosclerosis	0.00126	0.012	CcSEcCtD
Bumetanide—Polyuria—Niacin—atherosclerosis	0.00123	0.0117	CcSEcCtD
Bumetanide—Cramp muscle—Lovastatin—atherosclerosis	0.00113	0.0108	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.00113	0.0108	CcSEcCtD
Bumetanide—Cramp muscle—Ezetimibe—atherosclerosis	0.00111	0.0106	CcSEcCtD
Bumetanide—PTGS2—appendage—atherosclerosis	0.0011	0.047	CbGeAlD
Bumetanide—Pancreatitis—Lovastatin—atherosclerosis	0.00107	0.0101	CcSEcCtD
Bumetanide—Cramp muscle—Simvastatin—atherosclerosis	0.00106	0.0101	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.00106	0.0101	CcSEcCtD
Bumetanide—Pancreatitis—Ezetimibe—atherosclerosis	0.00105	0.00995	CcSEcCtD
Bumetanide—Abdominal discomfort—Lovastatin—atherosclerosis	0.00104	0.00992	CcSEcCtD
Bumetanide—CA5A—liver—atherosclerosis	0.00104	0.0441	CbGeAlD
Bumetanide—Pancreatitis—Simvastatin—atherosclerosis	0.000997	0.00949	CcSEcCtD
Bumetanide—SLC12A2—cardiovascular system—atherosclerosis	0.000994	0.0423	CbGeAlD
Bumetanide—Abdominal discomfort—Simvastatin—atherosclerosis	0.000975	0.00928	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000961	0.00914	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000958	0.00911	CcSEcCtD
Bumetanide—Cramp muscle—Pravastatin—atherosclerosis	0.000958	0.00911	CcSEcCtD
Bumetanide—Pancreatitis—Pravastatin—atherosclerosis	0.000902	0.00858	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000899	0.00855	CcSEcCtD
Bumetanide—SLC12A4—liver—atherosclerosis	0.000891	0.0379	CbGeAlD
Bumetanide—SLC12A2—adipose tissue—atherosclerosis	0.000876	0.0373	CbGeAlD
Bumetanide—CA12—connective tissue—atherosclerosis	0.000832	0.0354	CbGeAlD
Bumetanide—Erythema multiforme—Lovastatin—atherosclerosis	0.000823	0.00783	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000813	0.00773	CcSEcCtD
Bumetanide—Erythema multiforme—Ezetimibe—atherosclerosis	0.000807	0.00768	CcSEcCtD
Bumetanide—Sweating—Niacin—atherosclerosis	0.000798	0.00759	CcSEcCtD
Bumetanide—PTGS2—artery—atherosclerosis	0.00079	0.0336	CbGeAlD
Bumetanide—Erythema multiforme—Simvastatin—atherosclerosis	0.00077	0.00732	CcSEcCtD
Bumetanide—Arthralgia—Rosuvastatin—atherosclerosis	0.000761	0.00724	CcSEcCtD
Bumetanide—Muscle spasms—Lovastatin—atherosclerosis	0.000729	0.00693	CcSEcCtD
Bumetanide—Muscle spasms—Ezetimibe—atherosclerosis	0.000715	0.0068	CcSEcCtD
Bumetanide—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000715	0.0068	CcSEcCtD
Bumetanide—CFTR—liver—atherosclerosis	0.0007	0.0298	CbGeAlD
Bumetanide—Erythema multiforme—Pravastatin—atherosclerosis	0.000696	0.00662	CcSEcCtD
Bumetanide—Muscle spasms—Simvastatin—atherosclerosis	0.000681	0.00648	CcSEcCtD
Bumetanide—Vertigo—Lovastatin—atherosclerosis	0.000681	0.00648	CcSEcCtD
Bumetanide—Leukopenia—Lovastatin—atherosclerosis	0.000678	0.00645	CcSEcCtD
Bumetanide—PTGS2—endothelium—atherosclerosis	0.000667	0.0284	CbGeAlD
Bumetanide—CA5B—cardiovascular system—atherosclerosis	0.000649	0.0276	CbGeAlD
Bumetanide—Arthralgia—Lovastatin—atherosclerosis	0.000645	0.00614	CcSEcCtD
Bumetanide—Chest pain—Lovastatin—atherosclerosis	0.000645	0.00614	CcSEcCtD
Bumetanide—Vertigo—Simvastatin—atherosclerosis	0.000637	0.00606	CcSEcCtD
Bumetanide—Leukopenia—Simvastatin—atherosclerosis	0.000634	0.00604	CcSEcCtD
Bumetanide—Chest pain—Ezetimibe—atherosclerosis	0.000633	0.00602	CcSEcCtD
Bumetanide—Arthralgia—Ezetimibe—atherosclerosis	0.000633	0.00602	CcSEcCtD
Bumetanide—Dry mouth—Lovastatin—atherosclerosis	0.000631	0.006	CcSEcCtD
Bumetanide—Muscle spasms—Niacin—atherosclerosis	0.000626	0.00595	CcSEcCtD
Bumetanide—Dry mouth—Ezetimibe—atherosclerosis	0.000619	0.00589	CcSEcCtD
Bumetanide—Muscle spasms—Pravastatin—atherosclerosis	0.000616	0.00586	CcSEcCtD
Bumetanide—PTGS2—blood vessel—atherosclerosis	0.000615	0.0262	CbGeAlD
Bumetanide—SLC12A2—liver—atherosclerosis	0.000615	0.0262	CbGeAlD
Bumetanide—Thrombocytopenia—Lovastatin—atherosclerosis	0.000606	0.00576	CcSEcCtD
Bumetanide—Arthralgia—Simvastatin—atherosclerosis	0.000603	0.00574	CcSEcCtD
Bumetanide—Chest pain—Simvastatin—atherosclerosis	0.000603	0.00574	CcSEcCtD
Bumetanide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000597	0.00568	CcSEcCtD
Bumetanide—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000594	0.00565	CcSEcCtD
Bumetanide—Vertigo—Niacin—atherosclerosis	0.000585	0.00556	CcSEcCtD
Bumetanide—Leukopenia—Niacin—atherosclerosis	0.000583	0.00554	CcSEcCtD
Bumetanide—SLC10A1—liver—atherosclerosis	0.000581	0.0247	CbGeAlD
Bumetanide—Urticaria—Rosuvastatin—atherosclerosis	0.00058	0.00551	CcSEcCtD
Bumetanide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000577	0.00549	CcSEcCtD
Bumetanide—Vertigo—Pravastatin—atherosclerosis	0.000576	0.00548	CcSEcCtD
Bumetanide—CA14—liver—atherosclerosis	0.000574	0.0244	CbGeAlD
Bumetanide—Leukopenia—Pravastatin—atherosclerosis	0.000574	0.00546	CcSEcCtD
Bumetanide—CA5B—adipose tissue—atherosclerosis	0.000573	0.0244	CbGeAlD
Bumetanide—Thrombocytopenia—Simvastatin—atherosclerosis	0.000566	0.00539	CcSEcCtD
Bumetanide—Arthralgia—Niacin—atherosclerosis	0.000554	0.00527	CcSEcCtD
Bumetanide—Arthralgia—Pravastatin—atherosclerosis	0.000546	0.00519	CcSEcCtD
Bumetanide—Chest pain—Pravastatin—atherosclerosis	0.000546	0.00519	CcSEcCtD
Bumetanide—Dry mouth—Niacin—atherosclerosis	0.000542	0.00515	CcSEcCtD
Bumetanide—Fatigue—Lovastatin—atherosclerosis	0.000533	0.00507	CcSEcCtD
Bumetanide—SLC22A11—liver—atherosclerosis	0.00053	0.0226	CbGeAlD
Bumetanide—Asthenia—Rosuvastatin—atherosclerosis	0.000524	0.00498	CcSEcCtD
Bumetanide—Fatigue—Ezetimibe—atherosclerosis	0.000523	0.00497	CcSEcCtD
Bumetanide—SLC22A7—liver—atherosclerosis	0.000518	0.022	CbGeAlD
Bumetanide—Pruritus—Rosuvastatin—atherosclerosis	0.000516	0.00491	CcSEcCtD
Bumetanide—Hyperhidrosis—Niacin—atherosclerosis	0.000513	0.00488	CcSEcCtD
Bumetanide—Thrombocytopenia—Pravastatin—atherosclerosis	0.000512	0.00487	CcSEcCtD
Bumetanide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000506	0.00481	CcSEcCtD
Bumetanide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000506	0.00481	CcSEcCtD
Bumetanide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000499	0.00475	CcSEcCtD
Bumetanide—Fatigue—Simvastatin—atherosclerosis	0.000499	0.00474	CcSEcCtD
Bumetanide—Hypotension—Niacin—atherosclerosis	0.000496	0.00472	CcSEcCtD
Bumetanide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000496	0.00472	CcSEcCtD
Bumetanide—Urticaria—Lovastatin—atherosclerosis	0.000491	0.00467	CcSEcCtD
Bumetanide—Abdominal pain—Lovastatin—atherosclerosis	0.000489	0.00465	CcSEcCtD
Bumetanide—Dizziness—Rosuvastatin—atherosclerosis	0.000483	0.00459	CcSEcCtD
Bumetanide—Urticaria—Ezetimibe—atherosclerosis	0.000482	0.00458	CcSEcCtD
Bumetanide—Abdominal pain—Ezetimibe—atherosclerosis	0.00048	0.00456	CcSEcCtD
Bumetanide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000473	0.0045	CcSEcCtD
Bumetanide—Furosemide—ALB—atherosclerosis	0.000463	0.396	CrCbGaD
Bumetanide—Rash—Rosuvastatin—atherosclerosis	0.00046	0.00438	CcSEcCtD
Bumetanide—Dermatitis—Rosuvastatin—atherosclerosis	0.00046	0.00437	CcSEcCtD
Bumetanide—Urticaria—Simvastatin—atherosclerosis	0.00046	0.00437	CcSEcCtD
Bumetanide—Abdominal pain—Simvastatin—atherosclerosis	0.000457	0.00435	CcSEcCtD
Bumetanide—Headache—Rosuvastatin—atherosclerosis	0.000457	0.00435	CcSEcCtD
Bumetanide—Fatigue—Pravastatin—atherosclerosis	0.000451	0.00429	CcSEcCtD
Bumetanide—CA4—cardiovascular system—atherosclerosis	0.000448	0.0191	CbGeAlD
Bumetanide—Asthenia—Lovastatin—atherosclerosis	0.000444	0.00422	CcSEcCtD
Bumetanide—Pruritus—Lovastatin—atherosclerosis	0.000438	0.00416	CcSEcCtD
Bumetanide—Asthenia—Ezetimibe—atherosclerosis	0.000435	0.00414	CcSEcCtD
Bumetanide—Gastrointestinal pain—Niacin—atherosclerosis	0.000434	0.00413	CcSEcCtD
Bumetanide—Nausea—Rosuvastatin—atherosclerosis	0.000433	0.00412	CcSEcCtD
Bumetanide—Pruritus—Ezetimibe—atherosclerosis	0.000429	0.00408	CcSEcCtD
Bumetanide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000428	0.00407	CcSEcCtD
Bumetanide—Diarrhoea—Lovastatin—atherosclerosis	0.000423	0.00403	CcSEcCtD
Bumetanide—Urticaria—Niacin—atherosclerosis	0.000422	0.00401	CcSEcCtD
Bumetanide—Abdominal pain—Niacin—atherosclerosis	0.00042	0.00399	CcSEcCtD
Bumetanide—Urticaria—Pravastatin—atherosclerosis	0.000415	0.00395	CcSEcCtD
Bumetanide—Asthenia—Simvastatin—atherosclerosis	0.000415	0.00395	CcSEcCtD
Bumetanide—Diarrhoea—Ezetimibe—atherosclerosis	0.000415	0.00395	CcSEcCtD
Bumetanide—Abdominal pain—Pravastatin—atherosclerosis	0.000413	0.00393	CcSEcCtD
Bumetanide—Pruritus—Simvastatin—atherosclerosis	0.000409	0.00389	CcSEcCtD
Bumetanide—Dizziness—Lovastatin—atherosclerosis	0.000409	0.00389	CcSEcCtD
Bumetanide—Dizziness—Ezetimibe—atherosclerosis	0.000401	0.00382	CcSEcCtD
Bumetanide—Diarrhoea—Simvastatin—atherosclerosis	0.000396	0.00376	CcSEcCtD
Bumetanide—CA4—adipose tissue—atherosclerosis	0.000395	0.0168	CbGeAlD
Bumetanide—Vomiting—Lovastatin—atherosclerosis	0.000393	0.00374	CcSEcCtD
Bumetanide—Rash—Lovastatin—atherosclerosis	0.00039	0.00371	CcSEcCtD
Bumetanide—Dermatitis—Lovastatin—atherosclerosis	0.00039	0.00371	CcSEcCtD
Bumetanide—Headache—Lovastatin—atherosclerosis	0.000387	0.00369	CcSEcCtD
Bumetanide—Vomiting—Ezetimibe—atherosclerosis	0.000386	0.00367	CcSEcCtD
Bumetanide—Dizziness—Simvastatin—atherosclerosis	0.000383	0.00364	CcSEcCtD
Bumetanide—Rash—Ezetimibe—atherosclerosis	0.000382	0.00364	CcSEcCtD
Bumetanide—Dermatitis—Ezetimibe—atherosclerosis	0.000382	0.00363	CcSEcCtD
Bumetanide—Asthenia—Niacin—atherosclerosis	0.000381	0.00363	CcSEcCtD
Bumetanide—Headache—Ezetimibe—atherosclerosis	0.00038	0.00361	CcSEcCtD
Bumetanide—Pruritus—Niacin—atherosclerosis	0.000376	0.00357	CcSEcCtD
Bumetanide—Asthenia—Pravastatin—atherosclerosis	0.000375	0.00357	CcSEcCtD
Bumetanide—Fenoprofen—PTGS2—atherosclerosis	0.000373	0.319	CrCbGaD
Bumetanide—Pruritus—Pravastatin—atherosclerosis	0.00037	0.00352	CcSEcCtD
Bumetanide—Vomiting—Simvastatin—atherosclerosis	0.000368	0.0035	CcSEcCtD
Bumetanide—Nausea—Lovastatin—atherosclerosis	0.000367	0.00349	CcSEcCtD
Bumetanide—Rash—Simvastatin—atherosclerosis	0.000365	0.00347	CcSEcCtD
Bumetanide—Dermatitis—Simvastatin—atherosclerosis	0.000364	0.00347	CcSEcCtD
Bumetanide—Diarrhoea—Niacin—atherosclerosis	0.000363	0.00346	CcSEcCtD
Bumetanide—Headache—Simvastatin—atherosclerosis	0.000362	0.00345	CcSEcCtD
Bumetanide—Nausea—Ezetimibe—atherosclerosis	0.00036	0.00343	CcSEcCtD
Bumetanide—Diarrhoea—Pravastatin—atherosclerosis	0.000358	0.0034	CcSEcCtD
Bumetanide—Dizziness—Niacin—atherosclerosis	0.000351	0.00334	CcSEcCtD
Bumetanide—Dizziness—Pravastatin—atherosclerosis	0.000346	0.00329	CcSEcCtD
Bumetanide—Nausea—Simvastatin—atherosclerosis	0.000344	0.00327	CcSEcCtD
Bumetanide—Vomiting—Niacin—atherosclerosis	0.000338	0.00321	CcSEcCtD
Bumetanide—Rash—Niacin—atherosclerosis	0.000335	0.00319	CcSEcCtD
Bumetanide—Dermatitis—Niacin—atherosclerosis	0.000335	0.00318	CcSEcCtD
Bumetanide—Headache—Niacin—atherosclerosis	0.000333	0.00317	CcSEcCtD
Bumetanide—Fenoprofen—ALB—atherosclerosis	0.000333	0.285	CrCbGaD
Bumetanide—Vomiting—Pravastatin—atherosclerosis	0.000333	0.00316	CcSEcCtD
Bumetanide—Rash—Pravastatin—atherosclerosis	0.00033	0.00314	CcSEcCtD
Bumetanide—Dermatitis—Pravastatin—atherosclerosis	0.000329	0.00313	CcSEcCtD
Bumetanide—Headache—Pravastatin—atherosclerosis	0.000328	0.00312	CcSEcCtD
Bumetanide—Nausea—Niacin—atherosclerosis	0.000316	0.003	CcSEcCtD
Bumetanide—PTGS2—connective tissue—atherosclerosis	0.000315	0.0134	CbGeAlD
Bumetanide—SLCO1A2—liver—atherosclerosis	0.000313	0.0133	CbGeAlD
Bumetanide—Nausea—Pravastatin—atherosclerosis	0.000311	0.00296	CcSEcCtD
Bumetanide—PTGS2—cardiovascular system—atherosclerosis	0.000274	0.0117	CbGeAlD
Bumetanide—PTGS2—adipose tissue—atherosclerosis	0.000242	0.0103	CbGeAlD
Bumetanide—PTGS2—liver—atherosclerosis	0.00017	0.00722	CbGeAlD
Bumetanide—SLCO1A2—Metabolism—ABCG5—atherosclerosis	2.61e-05	0.000287	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.61e-05	0.000287	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOB—atherosclerosis	2.6e-05	0.000286	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CG—atherosclerosis	2.6e-05	0.000286	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.6e-05	0.000286	CbGpPWpGaD
Bumetanide—CA4—Metabolism—HMOX1—atherosclerosis	2.59e-05	0.000285	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PPARG—atherosclerosis	2.57e-05	0.000283	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—APOB—atherosclerosis	2.57e-05	0.000283	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AGT—atherosclerosis	2.54e-05	0.00028	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LTA4H—atherosclerosis	2.54e-05	0.00028	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCG8—atherosclerosis	2.54e-05	0.00028	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GSTM1—atherosclerosis	2.53e-05	0.000278	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ALB—atherosclerosis	2.53e-05	0.000278	CbGpPWpGaD
Bumetanide—CA14—Metabolism—INS—atherosclerosis	2.53e-05	0.000278	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—LPA—atherosclerosis	2.52e-05	0.000277	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	2.51e-05	0.000276	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PPARG—atherosclerosis	2.51e-05	0.000276	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MAPK3—atherosclerosis	2.5e-05	0.000275	CbGpPWpGaD
Bumetanide—CA12—Metabolism—APOE—atherosclerosis	2.49e-05	0.000274	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IL6—atherosclerosis	2.49e-05	0.000274	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—LPL—atherosclerosis	2.48e-05	0.000273	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOB—atherosclerosis	2.48e-05	0.000273	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CAV1—atherosclerosis	2.47e-05	0.000271	CbGpPWpGaD
Bumetanide—CA12—Metabolism—APOA1—atherosclerosis	2.46e-05	0.000271	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—INS—atherosclerosis	2.46e-05	0.000271	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—BGN—atherosclerosis	2.44e-05	0.000269	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ABCA1—atherosclerosis	2.44e-05	0.000268	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.44e-05	0.000268	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CG—atherosclerosis	2.43e-05	0.000267	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CG—atherosclerosis	2.43e-05	0.000267	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.42e-05	0.000267	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GPX1—atherosclerosis	2.42e-05	0.000267	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TGFB1—atherosclerosis	2.42e-05	0.000266	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOA5—atherosclerosis	2.42e-05	0.000266	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GSTM1—atherosclerosis	2.41e-05	0.000266	CbGpPWpGaD
Bumetanide—CA4—Metabolism—LPL—atherosclerosis	2.37e-05	0.000261	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	2.37e-05	0.000261	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CD36—atherosclerosis	2.36e-05	0.00026	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.35e-05	0.000258	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PPARG—atherosclerosis	2.34e-05	0.000258	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PPARG—atherosclerosis	2.34e-05	0.000258	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PLA2G1B—atherosclerosis	2.33e-05	0.000256	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ALB—atherosclerosis	2.31e-05	0.000255	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GPX1—atherosclerosis	2.31e-05	0.000254	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	2.31e-05	0.000254	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.31e-05	0.000254	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.3e-05	0.000253	CbGpPWpGaD
Bumetanide—CA7—Metabolism—INS—atherosclerosis	2.3e-05	0.000253	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—INS—atherosclerosis	2.3e-05	0.000253	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ALB—atherosclerosis	2.3e-05	0.000252	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.28e-05	0.000251	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.27e-05	0.00025	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	2.26e-05	0.000249	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ALB—atherosclerosis	2.26e-05	0.000248	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CD36—atherosclerosis	2.25e-05	0.000248	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CG—atherosclerosis	2.25e-05	0.000247	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALOX5—atherosclerosis	2.25e-05	0.000247	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—MTHFR—atherosclerosis	2.24e-05	0.000246	CbGpPWpGaD
Bumetanide—CA14—Metabolism—NOS3—atherosclerosis	2.21e-05	0.000244	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOA4—atherosclerosis	2.21e-05	0.000243	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PPARA—atherosclerosis	2.19e-05	0.000241	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PPARG—atherosclerosis	2.17e-05	0.000239	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.17e-05	0.000238	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.16e-05	0.000238	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—NOS3—atherosclerosis	2.16e-05	0.000237	CbGpPWpGaD
Bumetanide—CA4—Metabolism—MTHFR—atherosclerosis	2.13e-05	0.000235	CbGpPWpGaD
Bumetanide—CA12—Metabolism—INS—atherosclerosis	2.13e-05	0.000234	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AGT—atherosclerosis	2.13e-05	0.000234	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	2.11e-05	0.000232	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ALB—atherosclerosis	2.11e-05	0.000232	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ALB—atherosclerosis	2.11e-05	0.000232	CbGpPWpGaD
Bumetanide—CA9—Metabolism—HMOX1—atherosclerosis	2.09e-05	0.00023	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PPARA—atherosclerosis	2.09e-05	0.00023	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOE—atherosclerosis	2.08e-05	0.000229	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.08e-05	0.000228	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CAV1—atherosclerosis	2.06e-05	0.000227	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOA1—atherosclerosis	2.06e-05	0.000226	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.03e-05	0.000224	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AGT—atherosclerosis	2.03e-05	0.000223	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—atherosclerosis	2.03e-05	0.000223	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NAMPT—atherosclerosis	2.02e-05	0.000222	CbGpPWpGaD
Bumetanide—CA7—Metabolism—NOS3—atherosclerosis	2.01e-05	0.000222	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—NOS3—atherosclerosis	2.01e-05	0.000222	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCG1—atherosclerosis	2.01e-05	0.000221	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOB—atherosclerosis	2.01e-05	0.000221	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2e-05	0.00022	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—LIPC—atherosclerosis	2e-05	0.00022	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOC3—atherosclerosis	1.99e-05	0.000219	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOE—atherosclerosis	1.99e-05	0.000218	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.98e-05	0.000218	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—LDLR—atherosclerosis	1.98e-05	0.000218	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—atherosclerosis	1.97e-05	0.000217	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CAV1—atherosclerosis	1.97e-05	0.000216	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOA1—atherosclerosis	1.96e-05	0.000216	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GSTM1—atherosclerosis	1.95e-05	0.000215	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALB—atherosclerosis	1.95e-05	0.000215	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.95e-05	0.000214	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CETP—atherosclerosis	1.93e-05	0.000213	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ALB—atherosclerosis	1.93e-05	0.000212	CbGpPWpGaD
Bumetanide—CA9—Metabolism—LPL—atherosclerosis	1.92e-05	0.000211	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOA2—atherosclerosis	1.91e-05	0.00021	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—FABP4—atherosclerosis	1.89e-05	0.000208	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LCAT—atherosclerosis	1.89e-05	0.000208	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CG—atherosclerosis	1.88e-05	0.000207	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GPX1—atherosclerosis	1.87e-05	0.000205	CbGpPWpGaD
Bumetanide—CA12—Metabolism—NOS3—atherosclerosis	1.87e-05	0.000205	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOA4—atherosclerosis	1.85e-05	0.000204	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SCARB1—atherosclerosis	1.85e-05	0.000204	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—atherosclerosis	1.84e-05	0.000203	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—atherosclerosis	1.84e-05	0.000203	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	1.83e-05	0.000201	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP7A1—atherosclerosis	1.82e-05	0.0002	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CD36—atherosclerosis	1.82e-05	0.0002	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PPARG—atherosclerosis	1.81e-05	0.000199	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.8e-05	0.000198	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.8e-05	0.000197	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CG—atherosclerosis	1.79e-05	0.000197	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—INS—atherosclerosis	1.78e-05	0.000196	CbGpPWpGaD
Bumetanide—PTGS2—Disease—BGN—atherosclerosis	1.76e-05	0.000194	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HMGCR—atherosclerosis	1.75e-05	0.000192	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.74e-05	0.000191	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PPARG—atherosclerosis	1.73e-05	0.00019	CbGpPWpGaD
Bumetanide—CA9—Metabolism—MTHFR—atherosclerosis	1.72e-05	0.00019	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ALB—atherosclerosis	1.71e-05	0.000188	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—atherosclerosis	1.71e-05	0.000188	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.7e-05	0.000187	CbGpPWpGaD
Bumetanide—CA4—Metabolism—INS—atherosclerosis	1.7e-05	0.000187	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPARA—atherosclerosis	1.69e-05	0.000186	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP27A1—atherosclerosis	1.68e-05	0.000185	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.66e-05	0.000182	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.65e-05	0.000181	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AGT—atherosclerosis	1.64e-05	0.00018	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALB—atherosclerosis	1.63e-05	0.000179	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.62e-05	0.000178	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	1.61e-05	0.000177	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOE—atherosclerosis	1.61e-05	0.000177	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PLA2G2A—atherosclerosis	1.6e-05	0.000176	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALOX5AP—atherosclerosis	1.6e-05	0.000176	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOA2—atherosclerosis	1.6e-05	0.000176	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALOX15—atherosclerosis	1.6e-05	0.000176	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CAV1—atherosclerosis	1.59e-05	0.000175	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOA1—atherosclerosis	1.59e-05	0.000175	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCG5—atherosclerosis	1.58e-05	0.000173	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.58e-05	0.000173	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.57e-05	0.000173	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—NOS3—atherosclerosis	1.56e-05	0.000172	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ABCA1—atherosclerosis	1.56e-05	0.000171	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALB—atherosclerosis	1.56e-05	0.000171	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.54e-05	0.000169	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CST3—atherosclerosis	1.53e-05	0.000169	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LPA—atherosclerosis	1.52e-05	0.000167	CbGpPWpGaD
Bumetanide—CA4—Metabolism—NOS3—atherosclerosis	1.49e-05	0.000164	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—BGN—atherosclerosis	1.47e-05	0.000162	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.46e-05	0.000161	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOA5—atherosclerosis	1.46e-05	0.000161	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NAMPT—atherosclerosis	1.45e-05	0.00016	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CG—atherosclerosis	1.45e-05	0.000159	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOC3—atherosclerosis	1.44e-05	0.000158	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—atherosclerosis	1.43e-05	0.000157	CbGpPWpGaD
Bumetanide—PTGS2—Disease—LDLR—atherosclerosis	1.43e-05	0.000157	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.42e-05	0.000156	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PLA2G1B—atherosclerosis	1.41e-05	0.000155	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPARG—atherosclerosis	1.4e-05	0.000154	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.39e-05	0.000153	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HSPA1B—atherosclerosis	1.38e-05	0.000152	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.38e-05	0.000151	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.37e-05	0.000151	CbGpPWpGaD
Bumetanide—CA9—Metabolism—INS—atherosclerosis	1.37e-05	0.000151	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—atherosclerosis	1.36e-05	0.00015	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALOX5—atherosclerosis	1.36e-05	0.000149	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—HMOX1—atherosclerosis	1.34e-05	0.000147	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NCF1—atherosclerosis	1.33e-05	0.000147	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOB—atherosclerosis	1.28e-05	0.000141	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALB—atherosclerosis	1.26e-05	0.000138	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CYBA—atherosclerosis	1.25e-05	0.000138	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.25e-05	0.000138	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GSTM1—atherosclerosis	1.25e-05	0.000137	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PARP1—atherosclerosis	1.23e-05	0.000135	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—LPL—atherosclerosis	1.22e-05	0.000134	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NAMPT—atherosclerosis	1.22e-05	0.000134	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.21e-05	0.000133	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LIPC—atherosclerosis	1.21e-05	0.000133	CbGpPWpGaD
Bumetanide—CA9—Metabolism—NOS3—atherosclerosis	1.2e-05	0.000132	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOC3—atherosclerosis	1.2e-05	0.000132	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LDLR—atherosclerosis	1.19e-05	0.000131	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GPX1—atherosclerosis	1.19e-05	0.000131	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CETP—atherosclerosis	1.17e-05	0.000128	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CD36—atherosclerosis	1.16e-05	0.000128	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.15e-05	0.000126	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SCARB1—atherosclerosis	1.12e-05	0.000123	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—MTHFR—atherosclerosis	1.1e-05	0.000121	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—atherosclerosis	1.1e-05	0.000121	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.09e-05	0.00012	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPARA—atherosclerosis	1.08e-05	0.000119	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HMGCR—atherosclerosis	1.06e-05	0.000116	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AGT—atherosclerosis	1.05e-05	0.000115	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOE—atherosclerosis	1.02e-05	0.000113	CbGpPWpGaD
Bumetanide—CA14—Metabolism—AKT1—atherosclerosis	1.02e-05	0.000112	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CAV1—atherosclerosis	1.02e-05	0.000112	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOA1—atherosclerosis	1.01e-05	0.000111	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—AKT1—atherosclerosis	9.92e-06	0.000109	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ABCA1—atherosclerosis	9.41e-06	0.000103	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—AKT1—atherosclerosis	9.26e-06	0.000102	CbGpPWpGaD
Bumetanide—CA7—Metabolism—AKT1—atherosclerosis	9.26e-06	0.000102	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CG—atherosclerosis	9.25e-06	0.000102	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOB—atherosclerosis	9.23e-06	0.000102	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPARG—atherosclerosis	8.92e-06	9.81e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—LPL—atherosclerosis	8.81e-06	9.69e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—INS—atherosclerosis	8.75e-06	9.63e-05	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AKT1—atherosclerosis	8.58e-06	9.43e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PRKCG—atherosclerosis	8.57e-06	9.42e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—HMOX1—atherosclerosis	8.07e-06	8.88e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALB—atherosclerosis	8.03e-06	8.82e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MTHFR—atherosclerosis	7.94e-06	8.73e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOB—atherosclerosis	7.73e-06	8.5e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PDGFB—atherosclerosis	7.72e-06	8.49e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—NOS3—atherosclerosis	7.68e-06	8.44e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GSTM1—atherosclerosis	7.52e-06	8.27e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOE—atherosclerosis	7.39e-06	8.13e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—LPL—atherosclerosis	7.38e-06	8.12e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CAV1—atherosclerosis	7.32e-06	8.05e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOA1—atherosclerosis	7.3e-06	8.03e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GPX1—atherosclerosis	7.2e-06	7.92e-05	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AKT1—atherosclerosis	7.17e-06	7.89e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—atherosclerosis	7.02e-06	7.72e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CD36—atherosclerosis	7.01e-06	7.71e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS2—atherosclerosis	6.89e-06	7.57e-05	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AKT1—atherosclerosis	6.84e-06	7.52e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—MTHFR—atherosclerosis	6.65e-06	7.31e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPARA—atherosclerosis	6.52e-06	7.17e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AGT—atherosclerosis	6.32e-06	6.94e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—INS—atherosclerosis	6.31e-06	6.94e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOE—atherosclerosis	6.19e-06	6.8e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CAV1—atherosclerosis	6.13e-06	6.74e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOA1—atherosclerosis	6.12e-06	6.73e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SERPINE1—atherosclerosis	5.8e-06	6.38e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CG—atherosclerosis	5.58e-06	6.14e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOS3—atherosclerosis	5.54e-06	6.09e-05	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AKT1—atherosclerosis	5.53e-06	6.08e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPARG—atherosclerosis	5.39e-06	5.93e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—INS—atherosclerosis	5.29e-06	5.81e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALB—atherosclerosis	4.85e-06	5.33e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—NOS3—atherosclerosis	4.64e-06	5.1e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STAT3—atherosclerosis	3.95e-06	4.34e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MAPK3—atherosclerosis	3.77e-06	4.15e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFB1—atherosclerosis	3.66e-06	4.03e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKT1—atherosclerosis	3.53e-06	3.88e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—atherosclerosis	2.76e-06	3.03e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKT1—atherosclerosis	2.54e-06	2.8e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKT1—atherosclerosis	2.13e-06	2.34e-05	CbGpPWpGaD
